Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Jacek Kubica
The UNICORN study is a multi-center, international, observational, phase IV clinical trial which is aimed to investigate whether MTH applied in patients with ACS and cardiac arrest treated with PCI is associated with better clinical outcomes as compared with therapy without MTH. This trial will provide important information regarding the impact of MTH in unconscious with a score of ≤8 on the Glasgow Coma Scale on admission to the hospital after out-of-hospital cardiac arrest (OHCA) with diagnosed or presumed ACS and shockable initial rhythm.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years
Survivor of OHCA
Sustained return of spontaneous circulation (ROSC) for more than 20 minutes after resuscitation
Unconsciousness with a score of ≤8 on the Glasgow Coma Scale after ROSC
Shockable initial rhythm
Diagnosis or suspicion of ACS
You may not be if
Unwitnessed OHCA
Obvious or suspected pregnancy
Known serious infection/sepsis before OHCA
Known bleeding diathesis
Confirmed or suspected internal bleeding
Confirmed or suspected acute stroke
Confirmed or suspected cerebral injury
Known serious neurological dysfunction (CPC≤4) before OHCA
Known serious disease making 180 days of survival unlikely
Hemodynamic instability with systolic blood pressure \<65 mmHg despite treatment
Time delay from ROSC to MTH induction \> 240 min.
Asystole or pulseless electrical activity (PEA) as the initial rhythm